Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemotherapy

  • Chih-Jen Yang1, 2, 4, 5,
  • Jen-Yu Hung2, 4,
  • Ming-Ju Tsai2,
  • Kuan-Li Wu2, 6,
  • Ta-Chih Liu3, 4,
  • Shah-Hwa Chou4, 7,
  • Jui-Ying Lee7,
  • Jui-Sheng Hsu4, 5Email author,
  • Ming-Shyan Huang2, 4, 5 and
  • Inn-Wen Chong2, 4Email author
Contributed equally
BMC Pharmacology and ToxicologyBMC series – open, inclusive and trusted201718:21

DOI: 10.1186/s40360-017-0130-0

Received: 11 December 2016

Accepted: 28 February 2017

Published: 10 May 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
11 Dec 2016 Submitted Original manuscript
25 Dec 2016 Reviewed Reviewer Report - Tao Che
25 Dec 2016 Reviewed Reviewer Report - Niki Karachaliou
10 Jan 2017 Author responded Author comments - Chih-Jen Yang
Resubmission - Version 2
10 Jan 2017 Submitted Manuscript version 2
13 Jan 2017 Reviewed Reviewer Report - Niki Karachaliou
15 Jan 2017 Reviewed Reviewer Report - Tao Che
24 Jan 2017 Author responded Author comments - Chih-Jen Yang
Resubmission - Version 3
24 Jan 2017 Submitted Manuscript version 3
11 Feb 2017 Author responded Author comments - Chih-Jen Yang
Resubmission - Version 4
11 Feb 2017 Submitted Manuscript version 4
Publishing
28 Feb 2017 Editorially accepted
10 May 2017 Article published 10.1186/s40360-017-0130-0

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University
(2)
Division of Pulmonary and Critical Care Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University
(3)
Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University
(4)
Faculty of Medicine, College of Medicine, Kaohsiung Medical University
(5)
Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University
(6)
Division of Chest Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University
(7)
Department of Medical Imaging, Kaohsiung Medical University Hospital, Kaohsiung Medical University

Advertisement